Dr. Ellen Herbst, MD

Claim this profile

San Francisco Veterans Affairs Medical Center

Studies Substance Abuse
Studies Nicotine Addiction
4 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
San Francisco Veterans Affairs Medical Center
Image of trial facility.
San Francisco VA Medical Center

Clinical Trials Ellen Herbst, MD is currently running

Image of trial facility.

Contingency Management

for Tobacco Use Disorder

Tobacco use among US Veterans poses significant health problems and challenges to their overall well-being. The aim of this project is to evaluate the effectiveness of a program called Contingency Management (CM) in helping Veterans quit smoking during lung cancer screening or cancer care at VA clinics. CM is a behavioral treatment that uses rewards to encourage smoking cessation when verified through biological testing. In the first year, the researchers will develop a mobile CM protocol based on feedback from Veterans and healthcare staff through focus groups. In the second year, they will conduct a pilot study to test the feasibility of the mobile CM program along with counseling and medication for 20 Veterans over a five-week period. The success of the pilot study will determine whether to proceed with a larger randomized controlled trial (RCT) in years three to six, comparing the efficacy of mobile CM with standard treatment. The project will take place at SFVA.
Recruiting1 award N/A1 criteria
Image of trial facility.

Contingency Management

for Tobacco Use Disorder

The goal of this study is to design and test the first mobile contingency management (CM) smoking cessation intervention for military Veterans undergoing major elective surgery. Smoking is the leading risk factor for postoperative complications and is associated with longer hospital stays, reoperations, and 30-day mortality. Smoking rates among patients undergoing major elective surgery are high, 22.3-43.0%. It is imperative to identify efficacious, strategically timed smoking cessation interventions for surgery patients. CM incentivizes smoking cessation through positive reinforcement (rewards) when bioverified abstinence is achieved. To ensure feasibility, CM must be tailored to the clinical context. CM for smoking cessation has never been delivered before and after major surgery, nor has mobile CM bioverification been trialed perioperatively. The investigators will develop and test a tailored mobile smoking cessation CM protocol for Veterans undergoing major elective surgery.
Recruiting1 award N/A

More about Ellen Herbst, MD

Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ellen Herbst, MD has experience with
  • Contingency Management
  • N-Acetyl Cysteine
  • Tech-Facilitated IC Intervention
  • VA Quitline

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Ellen Herbst, MD specialize in?
Is Ellen Herbst, MD currently recruiting for clinical trials?
Are there any treatments that Ellen Herbst, MD has studied deeply?
What is the best way to schedule an appointment with Ellen Herbst, MD?
What is the office address of Ellen Herbst, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security